Summary Biota Pharmaceuticals, Inc (Biota) is a pharmaceutical company that carries out anti-infective drug discovery, development and its commercialization to treat respiratory diseases. It has four product candidates in clinical development which address viral infections, namely, vapendavir, oral broad spectrum capsid inhibitor of enteroviruses, including human rhinovirus; BTA074, a Phase 2 topical antiviral treatment for genital warts; BTA585, an oral fusion protein inhibitor that Biota is developing for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a long-acting neuraminidase inhibitor for influenza A and B infections. The Company also has a preclinical RSV non-fusion inhibitor program for its F-protein inhibitor BTA585. Biota is headquartered in Alpharetta, Georgia, the US. Biota Pharmaceuticals, Inc. (BOTA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed... Research Beam Model: Research Beam Product ID: 451700 250 USD New
Biota Pharmaceuticals, Inc. (BOTA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Biota Pharmaceuticals, Inc. (BOTA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Healthcare
  • Published On : March   2016
  • Pages : 29
  • Publisher : GlobalData
 
 
 
Summary

Biota Pharmaceuticals, Inc (Biota) is a pharmaceutical company that carries out anti-infective drug discovery, development and its commercialization to treat respiratory diseases. It has four product candidates in clinical development which address viral infections, namely, vapendavir, oral broad spectrum capsid inhibitor of enteroviruses, including human rhinovirus; BTA074, a Phase 2 topical antiviral treatment for genital warts; BTA585, an oral fusion protein inhibitor that Biota is developing for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a long-acting neuraminidase inhibitor for influenza A and B infections. The Company also has a preclinical RSV non-fusion inhibitor program for its F-protein inhibitor BTA585. Biota is headquartered in Alpharetta, Georgia, the US.

Biota Pharmaceuticals, Inc. (BOTA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Biota Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Biota Pharmaceuticals, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Biota Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Biota Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Biota Pharmaceuticals, Inc., Medical Devices Deals, 2010 to YTD 2016 9
Biota Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Biota Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Biota Acquires Antibacterial Drug Assets From MaxThera 11
Partnerships 12
AMRI Enters Into Co-Development Agreement With Biota Holdings For CS8958 12
Biota Holdings Terminates Co-Development Agreement With Boehringer Ingelheim 13
Merger 14
Nabi Biopharma Completes Merger With Biota 14
Licensing Agreements 16
Biota Holdings Plans To Enter Into Licensing Agreement For CS8958 16
Biota Holdings Announces Licensing Agreement For LANI And HRV Programs 17
Nabi BioPharma Enters Into License Agreement With GlaxoSmithKline 18
Equity Offering 20
Biota Pharma Plans to Raise USD25 Million in Public offering of Shares 20
Biota Pharma Completes Public Offering Of shares For US$29 Million 22
Acquisition 24
Biota Pharma Acquires Anaconda Pharma for up to USD38 Million 24
Biota Holdings Plans To Acquire A Pharma Company 25
Biota Pharmaceuticals, Inc. - Key Competitors 26
Key Employees 27
Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List Of Tables
List of Tables
Biota Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Key Facts, 2015 1
Biota Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Biota Pharmaceuticals, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Biota Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Biota Pharmaceuticals, Inc., Deals By Therapy Area, 2010 to YTD 2016 8
Biota Pharmaceuticals, Inc., Medical Devices Deals, 2010 to YTD 2016 9
Biota Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Biota Acquires Antibacterial Drug Assets From MaxThera 11
AMRI Enters Into Co-Development Agreement With Biota Holdings For CS8958 12
Biota Holdings Terminates Co-Development Agreement With Boehringer Ingelheim 13
Nabi Biopharma Completes Merger With Biota 14
Biota Holdings Plans To Enter Into Licensing Agreement For CS8958 16
Biota Holdings Announces Licensing Agreement For LANI And HRV Programs 17
Nabi BioPharma Enters Into License Agreement With GlaxoSmithKline 18
Biota Pharma Plans to Raise USD25 Million in Public offering of Shares 20
Biota Pharma Completes Public Offering Of shares For US$29 Million 22
Biota Pharma Acquires Anaconda Pharma for up to USD38 Million 24
Biota Holdings Plans To Acquire A Pharma Company 25
Biota Pharmaceuticals, Inc., Key Competitors 26
Biota Pharmaceuticals, Inc., Key Employees 27
Biota Pharmaceuticals, Inc., Other Locations 28
Biota Pharmaceuticals, Inc., Subsidiaries 28
List Of Figures
List of Figures
Biota Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Biota Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Biota Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Biota Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Biota Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Biota Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Biota Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Biota Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Biota Pharmaceuticals, Inc., Medical Devices Deals, 2010 to YTD 2016 9
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter